ArticleJournal of experimental & clinical cancer research : CR2024

Galectin-3 and cancer immunotherapy: a glycobiological rationale to overcome tumor immune escape.

Giorgia Scafetta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.